A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action

Molecular Endocrinology

Volumn 10, Issue 12, 1996, Pages 1519-1526

  McInerney, Eileen M ^a   Ince, B Avery ^b   Shapiro, David J ^a   Katzenellenbogen, Benita S ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHO CELL; DNA BINDING; ESTROGEN ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONE BINDING; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; ESTROGENS; MUTATION; POINT MUTATION; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0029856632     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.12.1519     Document Type: Article

References (35)

1. Tsai MJ, O'Malley, BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
2. Beato M, Herrlich P, Schütz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
3. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human oestrogen receptor. Cell 51:941-951
4. Fawell SE, Lees JA, White R, Parker MG 1990 Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962
5. Kumar V, Green S, Staub A, Chambon P 1986 Localisation of the oestradiol- binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5:2231-2236
6. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P 1989 The human estrogen receptor has two nonacidic transcriptional activation functions. Cell 59:477-487
7. Lees JA, Fawell SE, Parker MG 1989 Identification of two transactivation domains in the mouse estrogen receptor. Nucleic Acids Res 17:5477-5488
8. Tasset D, Tora L, Fromental C, Scheer E, Chambon P 1990 Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187
9. Webster NJ, Green S, Jin JR, Chambon P 1988 The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199-207
10. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
11. Beekman JM, Allan GF, Tsai SY, O'Malley BW 1993 Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol 7:1266-1274
12. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458
13. Cavailles V, Dauvois S, Danielian PS, Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013
14. LeDouarin B, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF 1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
15. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
16. Pham TA, Elliston JF, Nawaz Z, McDonnell DP, Tsai MJ, O'Malley BW 1991 Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers. Proc Natl Acad Sci USA 88:3125-3129
17. McDonnell DP, Nawaz Z, O'Malley BW 1991 In situ distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol 11:4350-4355
18. Damm K, Thompson C, Evans R 1989 Protein encoded by v-erb A functions as a thyroid hormone receptor antagonist. Nature 339:593-597
19. Privalsky M, Sharif M, Yamomoto K 1990 The viral erb A oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast. Cell 63:1277-1286
20. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ, Katzenellenbogen BS 1993 Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 268:14026-14032
21. Zavacki AM, Harney JW, Brent GA, Larsen PR 1993 Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol 7:1399-1407
22. Ince BA, Schodin DJ, Shapiro DJ, Katzenellenbogen BS 1995 Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Endocrinology 136:3194-3199
23. Schodin DJ, Zhuang Y, Shapiro DJ, Katzenellenbogen BS 1995 Analysis of the mechanisms that determine dominant negative estrogen receptor effectiveness. J Biol Chem 270:31163-31171
24. Wrenn CK, Katzenellenbogen BS 1993 Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J Biol Chem 268:24089-24098
25. Reese JC, Katzenellenbogen BS 1992 Examination of the DNA-binding abilities of estrogen receptor in whole cells: implications for hormone-independent transactivation and the action of the pure antiestrogen ICI 164,384. Mol Cell Biol 12:4531-4538
26. Mader S, Kumar V, deVerneuil H, Chambon P 1989 Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen- from a glucocorticoid-responsive element. Nature 338:271-274
27. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor, RXR-α. Nature 375:377-382
28. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
29. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RL 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
30. Wurtz JM, Bourguet W, Renaud JP, Vivat V, Chambon P, Moras D, Gronemeyer H 1996 A canonical structure for the ligand binding domain of nuclear receptors. Nature Struct Biol 3:87-94
31. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS 1996 Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter- specific action of these hormones. Mol Endocrinol 10:119-131
32. Pakdel F, Katzenellenbogen BS 1992 Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J Biol Chem 267:3429-3437
33. Reese JC, Katzenellenbogen BS 1991 Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res 19:6595-6602
34. Nielsen DA, Chang TC, Shapiro DJ 1989 A highly sensitive, mixed phase assay for chloramphenicol acetyl transferase activity in transfected cells. Anal Biochem 179:19-23
35. Wrenn CK, Katzenellenbogen BS 1990 Cross-linking of estrogen receptor to chromatin in intact MCF-7 human breast cancer cells. Mol Endocrinol 4:1647-1654